Then we studied the possible role of the most potent derivative (compound DBH2) on the apoptosis of CML cells, bone marrow cells from BCR-ABL transgenic mouse and human patients. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.